HCT/P Documentation Checklist
A structured documentation review helps healthcare professionals evaluate supplier transparency, understand supporting documentation, and improve regulatory literacy when reviewing Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) within the framework of 21 CFR Part 1271.
This educational checklist complements the HCT/P Supplier Evaluation Process by organizing documentation into major review categories. Rather than determining regulatory status or product quality, it provides a consistent framework for identifying documentation commonly reviewed during supplier evaluations.
Estimated Review Time: 8–10 minutes
Purpose of This Checklist
This checklist promotes a documentation-first methodology by helping healthcare professionals organize their review of donor eligibility, processing documentation, traceability, quality systems, regulatory information, and supporting records. It is intended as an educational reference and should be used together with applicable regulations, FDA guidance, and supplier documentation.
How to Use This Checklist
This checklist is designed to support a structured educational review of supplier documentation. It should not be interpreted as a regulatory determination, quality assessment, or product evaluation. Instead, it provides an organized framework for identifying documentation categories commonly reviewed during supplier due diligence.
Documentation should always be evaluated as a complete package. Individual records should be considered within the broader context of donor eligibility, processing methods, quality systems, traceability, and applicable regulatory requirements.
1. Donor Eligibility Documentation
Donor eligibility documentation helps establish the records associated with donor screening and qualification. Reviewing these materials provides educational context regarding documented donor evaluation procedures and traceability practices under 21 CFR Part 1271 Subpart C.
2. Processing & Handling Documentation
Processing documentation provides educational context regarding how human tissue is recovered, handled, preserved, processed, packaged, and prepared prior to distribution. Reviewing these records helps professionals understand documented manufacturing practices and the supporting information associated with tissue processing.
- ☐ Description of processing methods
- ☐ Preservation and storage procedures
- ☐ Environmental and handling controls
- ☐ Lot or batch identification records
Reference: Minimal Manipulation
Educational review should focus on understanding documented processing methods rather than making assumptions regarding regulatory classification or product performance.
3. Intended Use & Product Description
Product descriptions and intended use information provide important context when reviewing supplier documentation. Understanding how tissue is described and the intended structural function helps place documentation within the broader educational framework of HCT/P regulation.
- ☐ Product labeling and description
- ☐ Intended use aligned with tissue function
- ☐ Structural or cellular tissue classification
Reference: Homologous Use
Documentation should be evaluated together with supporting regulatory information rather than relying on labeling or promotional language alone.
4. Chain of Custody & Traceability
Traceability documentation supports understanding of how tissue is identified and tracked throughout recovery, processing, storage, and distribution. Maintaining documentation continuity contributes to transparency throughout the educational review process.
- ☐ Unique identifier (lot or batch tracking)
- ☐ Chain of custody documentation
- ☐ Storage and handling logs
- ☐ Distribution records
Reference: Chain of Custody & Traceability
Traceability documentation should be reviewed together with donor eligibility and processing documentation to understand the complete documentation package.
5. Establishment & Regulatory Information
Regulatory documentation provides context regarding establishment operations and publicly available regulatory information. These materials contribute to understanding the documented regulatory environment but should not be interpreted as evidence of FDA approval, product endorsement, or clinical effectiveness.
- ☐ FDA establishment registration
- ☐ Product listing information (when applicable)
- ☐ Available inspection or compliance records
Reference: FDA Establishment Registration
Using This Checklist Effectively
A documentation checklist is most valuable when used as part of a structured review methodology rather than as a simple list of required documents. Documentation should be evaluated collectively to understand how regulatory information, donor eligibility records, processing documentation, traceability records, and quality systems support one another within the overall documentation package.
No single document should be interpreted independently or used to determine regulatory status, product quality, or clinical performance. Instead, each category contributes educational context that supports a more complete understanding of supplier documentation.
Documentation Review Best Practices
- Review documentation as a complete package rather than as individual records.
- Use consistent evaluation criteria across every supplier reviewed.
- Request clarification whenever documentation appears incomplete or unclear.
- Differentiate publicly available regulatory information from supplier-provided documentation.
- Document observations objectively without relying on marketing claims or promotional language.
- Maintain a documentation-first approach throughout the evaluation process.
Continue Your Documentation Review
This checklist represents one component of the broader Supplier Documentation Knowledge Center. The following educational resources expand on each stage of the documentation review process and provide additional context for healthcare professionals conducting structured supplier evaluations.
Frequently Asked Questions
Does this checklist determine regulatory compliance?
No. This checklist is an educational organizational tool intended to support structured documentation review. It does not determine regulatory status or compliance.
Should every supplier provide identical documentation?
Documentation packages may differ depending on the product category, manufacturing processes, regulatory pathway, and organizational practices. This checklist identifies documentation categories commonly reviewed rather than mandatory documentation requirements.
Does FDA establishment registration indicate FDA approval?
No. FDA establishment registration under 21 CFR Part 1271 does not constitute FDA approval, clearance, endorsement, or evaluation of safety or effectiveness.
Who should use this checklist?
This educational resource is intended for licensed healthcare professionals, healthcare organizations, compliance personnel, procurement teams, researchers, and other qualified professionals evaluating supplier documentation.
Regulatory Notice
This checklist is provided for educational purposes only.
It is intended to support documentation organization and regulatory literacy and should not be interpreted as a regulatory determination, legal opinion, or clinical recommendation.
Registration under 21 CFR Part 1271 does not constitute FDA approval, clearance, endorsement, or evaluation of safety or effectiveness.
Not By Chance Life LLC provides regulatory education and documentation transparency resources and does not manufacture, recover, process, store, package, label, distribute, or administer Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).
This information is not intended to diagnose, treat, cure, or prevent any disease.